Agere Augments Leadership with Pharmaceutical Manufacturing and Supply Chain Expert

  Agere Augments Leadership with Pharmaceutical Manufacturing and Supply Chain

        Solubility CDMO Adds VP to Head cGMP Manufacturing Operations

Business Wire

BEND, Ore. -- May 29, 2013

Agere Pharmaceuticals, Inc., a leading oral bioavailability contract
development and manufacturing organization (CDMO), announced today that Mr.
Michael R. Deperro has joined the company as VP of Operations. The company
added cGMP manufacturing capabilities in 2011, and since has expanded
facilities to produce Phase I through Phase IIb clinical trials materials for

“Mike brings Agere extensive experience and a strong track record for
successfully managing and growing cGMP operations,” commented Marshall Crew,
President and CEO of Agere. “He will play a key role as we continue our rapid
growth to meet the rigorous expectations of our clients.”

Mr. Deperro has held director and GM-level manufacturing positions at numerous
pharmaceutical companies including Alkermes (NASDAQ: ALKS) and Taro
Pharmaceuticals (NYSE: TARO). He has also been responsible for implementing
research and manufacturing infrastructure and operations domestically and
abroad for large pharmaceutical and biotechnology companies including Merck
and Co. (NYSE: MRK) and Novartis (NYSE: NVS). Mr. Deperro’s career focus has
been in the areas of drug development, new product launch, and
commercialization. His regulatory compliance knowledge of FDA, MHRA, PMDA and
ANVISA agencies enhances Agere’s strength in meeting the needs of a growing
international client base. Mr. Deperro holds the Bachelor of Science degree in
Mechanical Engineering from Notre Dame University, and has earned the Six
Sigma Yellow Belt status from the International Society for Six Sigma

For information about Mr. Deperro and Agere, please visit

About Agere

Agere is a leading CDMO focused on improving the oral bioavailability of
insoluble APIs. The company supports clients from formulation design and
development through cGMP manufacturing for Phase I through Phase IIb clinical
trials. Agere is expert in solid dispersion techniques and in a broad
selection of solid dosage forms. The company is recognized for its
solubilization knowledge and use of fundamental science and novel technologies
to achieve best outcomes for clients. All services are delivered on a
fee-for-service basis, and every project is customized to overcome the
specific challenges associated with each insoluble compound. Agere is located
in Bend, OR.

©2013 Agere Pharmaceuticals, Inc. Agere Pharmaceuticals is a trademark of
Agere Pharmaceuticals, Inc.


Agere Pharmaceuticals, Inc.
Casey Jones, +01-702-994-0605
Press spacebar to pause and continue. Press esc to stop.